Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of opioids.

Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a $7.4 billion settlement for their role in the opioid crisis.